Clinical Trial Update: Phase 3 Study of Yimitasvir Phosphate Capsules [Phase 3]

View source ↗

Summary

Phase 3 study completed for Yimitasvir Phosphate Capsules in chronic hepatitis C virus infection.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Yimitasvir Phosphate Capsules (Yimitasvir phosphate)

Snippet

Sponsor: Sunshine Lake Pharma Co., Ltd. | Conditions: Chronic HCV Infection | Phase 3 | Status: COMPLETED